Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-306 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87 |
filingDate |
2006-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2051d4daa60f6b5d631e60b41f0abc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6eaf7e9c79719cb517a6539c32ddc0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4c646bc6ced38b3c8daf96f37cc262d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a94a87ff44837b815a0e9b33403a27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8042b9eabc581c70d021539b4b4d6c1 |
publicationDate |
2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2367921-T3 |
titleOfInvention |
PROCEDURE AND DEVICES FOR THE SUPPLY OF A THERAPEUTIC PRODUCT TO THE EYE SPHERE OF A PATIENT. |
abstract |
Use of a therapeutic deoxyribonucleic acid (DNA) for the preparation of a composition for the treatment of an eye disease by administering said composition in the tissue or cells of the ciliary muscle of the subject to be treated, the administration comprising an injection step and an electroporation stage that involves the application of an electric field. |
priorityDate |
2005-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |